Wire Stories

Category Added in a WPeMatico Campaign

EyeBio_Logo

EyeBio Announces First Patients Dosed in Phase 1b/2 Trial of Restoretâ„¢ in Neovascular Age Related Macular Degeneration and Diabetic Macular Edema

- AMARONE (Anti-permeability Mechanism and Age-Related Ocular Neovascularization Evaluation) is first clinical trial of EyeBio’s lead asset Restoret, a Wnt...

NEXT_Horiz_FullColor_Logo_-_Copy

NextDecade Announces Framework Agreements with Global Infrastructure Partners and TotalEnergies to Support the Development of the Rio Grande LNG Project

  HOUSTON--(BUSINESS WIRE)--NextDecade Corporation (NextDecade) (NASDAQ: NEXT) today announced that it has entered into framework agreements with Global Infrastructure Partners...